Author

S. d. S. G. Dias

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 4 Organism:human· 4 Assay:proteomics· 2 Assay:bulk RNA-seq· 1

Frequent Co-Authors

N. Fintelman-Rodrigues· 4 shared C. Q. Sacramento· 3 shared J. R. Temerozo· 3 shared P. T. Bozza· 3 shared T. M. L. Souza· 3 shared C. d. S. G. Pedrosa· 2 shared C. Verissimo· 2 shared D. Biagi· 2 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCell Biology

N. Fintelman-Rodrigues

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

BiochemistrybioRxivPreprintApr 16, 2021

SARS-CoV-2 proteins bind heme and hemoglobin

S. G. De-Simone, G. C. Lechuga, F. Souza-Silva…·T. M. De-Simone

This paper shows SARS-CoV-2 proteins bind hemin and hemoglobin, with hemin inhibiting viral replication and interacting with the Spike protein's RBD region.

DOI 10.1101/2021.04.16.440124

humanproteomics

𝕏 PostBluesky

Cell BiologybioRxivPreprintFeb 20, 2021

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2

L. G. H. S. Aragao, J. T. Oliveira, J. R. Temerozo…·S. Rehen

This study examines the effects of the cannabinoid agonist WIN 55,212-2 on inflammation and cell survival in human iPSC-derived cardiomyocytes infected with SARS-CoV-2, finding reduced cytokine levels and cytotoxic damage.

DOI 10.1101/2021.02.20.431855

humanbulk RNA-seq

𝕏 PostBluesky

Cell BiologybioRxivPreprintFeb 20, 2021

Inhibition of SARS-CoV-2 infection in human cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoskeleton architecture and contractility

J. A. Salerno, T. Torquato, J. R. Temerozo…·S. Rehen

This study shows that inhibiting the Sigma-1 receptor with NE-100 reduces SARS-CoV-2 infection in human cardiomyocytes but also impairs cytoskeleton and contractility.

DOI 10.1101/2021.02.20.432092

humanexperimental assay

𝕏 PostBluesky

ImmunologybioRxivJul 25, 2020

VIP plasma levels associate with survival in severe COVID-19 patients, correlating with protective effects in SARS-CoV-2-infected cells.

J. R. Temerozo, C. Q. Sacramento, N. Fintelman-Rodrigues…·D. C. Bou-Habib

The paper shows elevated VIP plasma levels in severe COVID-19 patients correlate with survival and protective effects against SARS-CoV-2 in vitro.

DOI 10.1002/jlb.5cova1121-626r

humanproteomics

𝕏 PostBluesky